RAY1225
A Study of RAY1225 in Participants With Obesity
Guangdong Raynovent Biotech Co · Phase 2 · Recruiting · Enrollment 270
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| RAY1225 (cohort 1) | Obesity or overweight | n/r | n/r | n/r | n/r |
| Placebo (cohort 1) | Obesity or overweight | n/r | n/r | n/r | n/r |
| RAY1225 (cohort 2) | Obesity or overweight | n/r | n/r | n/r | n/r |
| Placebo (cohort 2) | Obesity or overweight | n/r | n/r | n/r | n/r |